ARTICLES

Filter  
Active filters 0
Remove
  

Refine your searches by:

Collections
Medicine / Cardiology
Sports
Public health

Languages

Countries
Greece
Brazil
Poland

Years
2020
2019
2017
2016

Filter  
 
5  Articles
1 of 1 pages  |  10  records  |  more records»
The increasing use of the non-vitamin K oral anticoagulants during the recent years was associated with the need of development of targeted agents that could reverse the anticoagulative activity in cases of severe bleeding episodes or urgent high risk ope... see more

A fibrilação atrial apresenta como complicação a ocorrência de eventos tromboembólicos, sendo necessária, como forma de prevenção, a implementação de anticoagulantes no tratamento desse grupo de pacientes. Porém, o grande desafio atualmente é buscar uma t... see more

For several decades the vitamin K antagonist oral anticoagulants were the only outpatient therapy that existed to reduce the risk of stroke and thromboembolism until non-vitamin K oral anticoagulants (NOACs). Direct thrombin inhibitor: dabigatran and fact... see more

ESC Meeting: Paris, 31/8-4/9/2019TCT Meeting: San Francisco, 25-28/9/2019HCS 40th Congress: Ioannina, 17-19/10/2019AHA Meeting: Philadelphia, PA, USA, 16-18/11/2019ACC Meeting: Chicago, IL, USA, 28-30/3/2020EHRA Meeting: Vienna, 29-31/3/2020Rhythmos 2019;... see more

Over the recent years, new oral anticoagulant agents have been developed and entered the clinical arena, the direct or non-vitamin K oral anticoagulants (NOACs). Although more expensive, these agents have been proven as equivalent or superior to vitamin K... see more

1 of 1 pages  |  10  records  |  more records»